SCHEMBL9010739

SCHEMBL9010739

Fc1ccc(C(CCCN2CC3CC(c4ccccc4)C3C2)c2ccc(F)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 1/20 0.44
HTR2A P28223 6/20 0.43
ADRA1A P35348 6/20 0.43
HRH1 P35367 6/20 0.43
DRD3 P35462 6/20 0.43
OPRK1 P41145 6/20 0.43
SLC6A3 Q01959 6/20 0.43
OPRD1 P41143 5/20 0.43
OPRM1 P35372 5/20 0.43
HTR6 P50406 5/20 0.43
CACNA1C Q13936 5/20 0.43
HTR2C P28335 4/20 0.43
CACNA1F O60840 4/20 0.43
DRD4 P21917 4/20 0.43
HRH2 P25021 4/20 0.43
CACNA1D Q01668 4/20 0.43
CACNA1S Q13698 4/20 0.43
DRD5 P21918 3/20 0.43
ADRA1D P25100 3/20 0.43
HTR7 P34969 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9010705 0.95 SCN5A (0.44) SLC18A3HTR2AADRA1AHRH1DRD3
SCHEMBL7779086 0.91 SLC18A3 (0.56) SLC18A3DRD3SLC6A3DRD2CYP1A2
SCHEMBL7781788 0.86 SLC18A3 (0.50) SLC18A3DRD3SLC6A3DRD2CYP1A2
SCHEMBL8989703 0.84 SLC18A3 (0.47) SLC18A3DRD3DRD2LMNACYP1A2
SCHEMBL7781274 0.83 HTR2A (0.45) HTR2AHRH1DRD3DRD4DRD5
SCHEMBL8989700 0.81 GRIN2B (0.45) SLC18A3HTR2AADRA1AHRH1DRD3
SCHEMBL7071917 0.80 KDM1A (0.51) HTR2AHRH1DRD3SLC6A3HTR6
SCHEMBL7781094 0.79 DRD2 (0.60) SLC18A3HTR2AADRA1AHRH1DRD3
SCHEMBL8989705 0.79 SLC18A3 (0.43) SLC18A3DRD3DRD2LMNACYP1A2
SCHEMBL8989732 0.79 PRCP (0.44) SLC6A3DRD2SLC6A4SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0646110-B1 N-SUBSTITUTED 3-AZABICYCLO[3.2.0]HEPTANE DERIVATIVES USEFUL AS NEUROLEPTIC AGENTS BASF AG (DE) 1996-10-23 EP disclosed
EP-0646110-A1 N-SUBSTITUED 3-AZABICYCLO 3.2.0]HEPTANE DERIVATIVES USEFUL AS NEUROLEPTIC AGENTS ETC. BASF AG (DE) 1995-04-05 EP disclosed
WO-1994000431-A1 N-SUBSTITUED 3-AZABICYCLO[3.2.0]HEPTANE DERIVATIVES USEFUL AS NEUROLEPTIC AGENTS ETC. BASF AKTIENGESELLSCHAFT (DE) 1994-01-06 WO disclosed